These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2881162)

  • 1. No change in corrected beta 2-microglobulin concentration after cuprophane haemodialysis.
    Bergström J; Wehle B
    Lancet; 1987 Mar; 1(8533):628-9. PubMed ID: 2881162
    [No Abstract]   [Full Text] [Related]  

  • 2. [What is the reason for the increase in beta-2-microglobulin levels in the blood when using cuprophane dialysis membranes?].
    Sulková S; Lapcík O; Votruba T
    Cas Lek Cesk; 1989 Apr; 128(17):520-3. PubMed ID: 2665936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of cuprophane membrane surface dialyzers on beta2-microglobulin serum concentration in patients during hemodialysis].
    Szepietowski T; el-Hayek A
    Polim Med; 1993; 23(3-4):43-54. PubMed ID: 8029157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Removal of silicon, aluminum and beta 2-microglobulin in chronic haemodialysis patients.
    Hosokawa S; Yoshida O
    Int Urol Nephrol; 1991; 23(3):281-4. PubMed ID: 1889973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta 2-microglobulin kinetics during haemodialysis and haemofiltration.
    Flöge J; Granolleras C; Bingel M; Deschodt G; Branger B; Oules R; Koch KM; Shaldon S
    Nephrol Dial Transplant; 1987; 1(4):223-8. PubMed ID: 3110678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of dialysis membrane on serum beta 2-microglobulin (beta 2M) in chronic haemodialysis patients.
    Farrell J; Bastani B
    Nephrol Dial Transplant; 1997 Apr; 12(4):856. PubMed ID: 9141041
    [No Abstract]   [Full Text] [Related]  

  • 7. Leucocyte occlusion of cuprophane membranes as a cause of reduced hemodialysis efficiency.
    Dodd NJ; Parsons V; Weston MJ
    Int J Artif Organs; 1982 Jul; 5(4):275-6. PubMed ID: 7118290
    [No Abstract]   [Full Text] [Related]  

  • 8. Do different dialysis-membranes affect beta 2-microglobulin kinetics during chronic hemodialysis?
    Risler T; Braun N; Hanel KD; Kuhlmann U; Skroch D; Müller GA
    Int J Artif Organs; 1994 Nov; 17(11):581-4. PubMed ID: 7744517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
    MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A
    Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biocompatibility of a new high-permeability modified cellulose membrane for haemodialysis.
    Ward RA; Schaefer RM; Falkenhagen D; Joshua MS; Heidland A; Klinkmann H; Gurland HJ
    Nephrol Dial Transplant; 1993; 8(1):47-53. PubMed ID: 8381935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dialysis arthropathy, beta 2-microglobulin and the effect of dialyser membrane.
    Sethi D; Gower PE
    Nephrol Dial Transplant; 1988; 3(6):768-72. PubMed ID: 3147418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal T lymphocyte function in patients with end-stage renal disease hemodialyzed with 'high-flux' polysulfone membranes.
    Degiannis D; Czarnecki M; Donati D; Homer L; Eisinger RP; Raska K; Raskova J
    Am J Nephrol; 1990; 10(4):276-82. PubMed ID: 2240054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodialysis membranes, serum beta 2-microglobulin, and dialysis amyloidosis.
    Hauglustaine D; Waer M; Michielsen P; Goebels J; Vandeputte M
    Lancet; 1986 May; 1(8491):1211-2. PubMed ID: 2871445
    [No Abstract]   [Full Text] [Related]  

  • 14. Intradialytic body weight changes and dialyzer pore size as main contributing factors to the evolution of beta-2-microglobulin in dialysis.
    Vanholder RC; Ringoir SM
    Blood Purif; 1990; 8(1):32-44. PubMed ID: 2198890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta 2-microglobulin associated amyloidosis and therapy with high flux hemodialysis membranes.
    Floege J; Koch KM
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S52-6. PubMed ID: 7923985
    [No Abstract]   [Full Text] [Related]  

  • 16. Beta 2-microglobulin serum levels during dialysis: effect of cuprophan and serum osmolality changes.
    Sulková S; Votruba T; Lapcík O; Válek A
    Int J Artif Organs; 1990 Jan; 13(1):22-5. PubMed ID: 2203684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of hemodialysis on levels of parathormone in blood of patients with chronic kidney failure].
    Starzyk J; Kowalski D
    Wiad Lek; 1993 Apr; 46(7-8):283-5. PubMed ID: 8249416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cuprophane haemodialysis induces upregulation of LPS receptor (CD14) on monocytes: role of complement activation.
    Marchant A; Tielemans C; Husson C; Gastaldello K; Schurmans T; De Groote D; Duchow J; Vanherweghem L; Goldman M
    Nephrol Dial Transplant; 1996 Apr; 11(4):657-62. PubMed ID: 8671854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-trace protein is highly removed during haemodialysis with high-flux and super high-flux membranes.
    Donadio C; Tognotti D; Caponi L; Paolicchi A
    BMC Nephrol; 2017 Feb; 18(1):68. PubMed ID: 28219328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of a new high-flux cellulose acetate membrane.
    Schaefer RM; Huber L; Gilge U; Bausewein K; Vienken J; Heidland A
    Int J Artif Organs; 1989 Feb; 12(2):85-90. PubMed ID: 2651325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.